These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report. Girolami A, Peruffo R, Emanueli A. Arzneimittelforschung; 1977; 27(6):1202. PubMed ID: 578441 [Abstract] [Full Text] [Related]
11. [Effect of furosemide on human blood coagulation, fibrinolysis and thrombocyte function]. Harenberg J, Walter E, Zimmermann R, Spohr U, Weber E. Verh Dtsch Ges Inn Med; 1978; (84):1375-8. PubMed ID: 741970 [No Abstract] [Full Text] [Related]
12. [Effect of pyridinolcarbamate (parmidine) on some bradykinin effects]. Shvarts GIa, Mashkovskiĭ MD. Farmakol Toksikol; 1976; 39(2):176-9. PubMed ID: 1278349 [Abstract] [Full Text] [Related]
13. [Pyridinolcarbamate in diabetic angiopathies]. Indovina I, Furitano G, Notarbartolo A, Citarrella P, Scaffidi A. Minerva Med; 1978 May 12; 69(24):1681-97. PubMed ID: 566399 [No Abstract] [Full Text] [Related]
14. Inhibition of human blood clotting by extracts of Ascaris suum. Crawford GP, Howse DJ, Grove DI. J Parasitol; 1982 Dec 12; 68(6):1044-7. PubMed ID: 7175610 [Abstract] [Full Text] [Related]
15. [Effect of thrombomodulin on specific thrombin functions: fibrinogen coagulation and thrombocyte aggregation]. Luk'ianenko EF, Kireeva EG, Strukova SM. Biull Eksp Biol Med; 1988 Nov 12; 106(11):517-9. PubMed ID: 2848597 [Abstract] [Full Text] [Related]